24Nov 2023
Optimal Treatment Strategies for Resectable Locally Advanced Esophageal Squamous Cell Carcinoma

Optimal Treatment Strategies for Resectable Locally Advanced Esophageal Squamous Cell Carcinoma

The study investigated treatment approaches for locally resectable esophageal squamous cell carcinoma (ESCC), comparing neoadjuvant chemotherapy followed by surgery (NCT+S), neoadjuvant chemoradiotherapy followed by surgery (NCRT+S), and surgery followed by chemoradiotherapy (S+CRT). Analyzing 715 patients, post-matching results revealed significant differences in 5-year disease-free survival (DFS) and overall survival (OS), favoring neoadjuvant therapy. However, neoadjuvant therapy correlates with higher postoperative anastomotic leakage rates. The study suggests that neoadjuvant therapy confers a survival advantage for ESCC patients, despite increased postoperative complications, emphasizing the importance of treatment strategy in managing locally advanced ESCC.

  • #general medicine

Like

Save

Share